Literature DB >> 18591271

Effects of subinhibitory concentrations of antibiotics on SOS and DNA repair gene expression in Staphylococcus aureus.

Lili Rosana Mesak1, Vivian Miao, Julian Davies.   

Abstract

Reporter clones of Staphylococcus aureus with different SOS response- and DNA repair-associated promoter-lux gene fusion constructs were constructed to study the effects of sub-MICs of antibiotics on the transcription of the SOS and methyl mismatch repair (MMR) genes. Fluoroquinolones (FQs) upmodulated both the SOS and the MMR genes. The patterns of antibiotic-induced transcriptional modulation were altered in FQ-resistant mutants.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18591271      PMCID： PMC2533449          DOI： 10.1128/AAC.01599-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  29 in total

1.  Dual effects of MLS antibiotics: transcriptional modulation and interactions on the ribosome.

Authors:  Wayne H W Tsui; Grace Yim; Helena Huimi Wang; JoAnn E McClure; Michael G Surette; Julian Davies
Journal:  Chem Biol       Date:  2004-09

2.  Subinhibitory cerulenin inhibits staphylococcal exoprotein production by blocking transcription rather than by blocking secretion.

Authors:  Rajan P Adhikari; Richard P Novick
Journal:  Microbiology       Date:  2005-09       Impact factor: 2.777

3.  Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus.

Authors:  Hiep N'Guyen Trong; Anne-Laure Prunier; Roland Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

4.  Induction and inhibition of ciprofloxacin resistance-conferring mutations in hypermutator bacteria.

Authors:  Ryan T Cirz; Floyd E Romesberg
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

5.  Staphylococcal coagulase; mode of action and antigenicity.

Authors:  E S DUTHIE; L L LORENZ
Journal:  J Gen Microbiol       Date:  1952-02

6.  Induction of fibronectin adhesins in quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin or by sigma B transcription factor activity is mediated by two separate pathways.

Authors:  Dongmei Li; Adriana Renzoni; Tristan Estoppey; Carmelo Bisognano; Patrice Francois; William L Kelley; Daniel P Lew; Jacques Schrenzel; Pierre Vaudaux
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

7.  Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates.

Authors:  Stephen H Gillespie; Shreya Basu; Anne L Dickens; Denise M O'Sullivan; Timothy D McHugh
Journal:  J Antimicrob Chemother       Date:  2005-06-14       Impact factor: 5.790

8.  Role of mutS and mutL genes in hypermutability and recombination in Staphylococcus aureus.

Authors:  Anne-Laure Prunier; Roland Leclercq
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

9.  Susceptibility and resistance genes to fluoroquinolones in methicillin-resistant Staphylococcus aureus isolated in 2002.

Authors:  Norihisa Noguchi; Takeshi Okihara; Yuta Namiki; Yuichi Kumaki; Yoshihiro Yamanaka; Masaharu Koyama; Kazunori Wakasugi; Masanori Sasatsu
Journal:  Int J Antimicrob Agents       Date:  2005-05       Impact factor: 5.283

10.  Favourable effects of sub-MIC rufloxacin concentrations in decreasing the pathogen-host cell adhesion.

Authors:  P C Braga; G Piatti
Journal:  Pharmacol Res       Date:  1993 Jul-Aug       Impact factor: 7.658
View more
  37 in total

1.  Quinolone induction of qnrVS1 in Vibrio splendidus and plasmid-carried qnrS1 in Escherichia coli, a mechanism independent of the SOS system.

Authors:  Ryo Okumura; Chun-Hsing Liao; Mariah Gavin; George A Jacoby; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Screening of a Leptospira biflexa mutant library to identify genes involved in ethidium bromide tolerance.

Authors:  Helena Pětrošová; Mathieu Picardeau
Journal:  Appl Environ Microbiol       Date:  2014-07-25       Impact factor: 4.792

Review 3.  Insights into microbial cryptic gene activation and strain improvement: principle, application and technical aspects.

Authors:  Kozo Ochi
Journal:  J Antibiot (Tokyo)       Date:  2016-07-06       Impact factor: 2.649

4.  Antibiotic modulation of the plasminogen binding ability of viridans group streptococci.

Authors:  Cristina Teles; Andrew Smith; Sue Lang
Journal:  Antimicrob Agents Chemother       Date:  2011-10-28       Impact factor: 5.191

5.  Impact of ciprofloxacin exposure on Staphylococcus aureus genomic alterations linked with emergence of rifampin resistance.

Authors:  Jean-Philippe Didier; Régis Villet; Elzbieta Huggler; Daniel P Lew; David C Hooper; William L Kelley; Pierre Vaudaux
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

Review 6.  DNA repair and genome maintenance in Bacillus subtilis.

Authors:  Justin S Lenhart; Jeremy W Schroeder; Brian W Walsh; Lyle A Simmons
Journal:  Microbiol Mol Biol Rev       Date:  2012-09       Impact factor: 11.056

Review 7.  Future target-based drug discovery for tuberculosis?

Authors:  Bavesh Davandra Kana; Petros C Karakousis; Tanya Parish; Thomas Dick
Journal:  Tuberculosis (Edinb)       Date:  2014-12       Impact factor: 3.131

Review 8.  4-Quinolones: smart phones of the microbial world.

Authors:  Holly Huse; Marvin Whiteley
Journal:  Chem Rev       Date:  2010-08-11       Impact factor: 60.622

9.  DNA Targeting as a Likely Mechanism Underlying the Antibacterial Activity of Synthetic Bis-Indole Antibiotics.

Authors:  Timothy J Opperman; Steven M Kwasny; Jessica Bo Li; Mark A Lewis; Daniel Aiello; John D Williams; Norton P Peet; Donald T Moir; Terry L Bowlin; Eric C Long
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

Review 10.  Role of reactive oxygen species in antibiotic action and resistance.

Authors:  Daniel J Dwyer; Michael A Kohanski; James J Collins
Journal:  Curr Opin Microbiol       Date:  2009-07-31       Impact factor: 7.934
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.